Caribou Biosciences (CRBU) shares were 40% higher pre-bell Monday after the company said its phase 1 trial of a treatment candidate for multiple myeloma showed an overall response rate of 92%.
Currenc Group (CURR) stock was up 34% after the company said it has offered to acquire Animoca Brands through a reverse merger.
IREN (IREN) shares were 22% higher after the company said it has secured a $9.70 billion GPU cloud services contract from Microsoft (MSFT) and a $5.80 billion deal with Dell Technologies (DELL) to purchase GPUs and related equipment.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments